The latest news from the Swiss NASH Foundation. In a joint effort to tackle the increasing prevalence and burden of NASH, scientific experts and the leading pharmaceutical companies have joined forces, read all out their latest research, findings and events.

Launched October 2019

The Swiss NASH Foundation was launched in October 2019, in Bern, Switzerland.

Read in full >

Multicenter Validation of Association Between Decline in MRI‐PDFF and histologic response

Dr @dufour_jf presenting Treatment of #NASH: What is in the pipeline, session Fatty liver disease: What’s new in 2020 #UEGWeek @my_ueg

Inventiva receives FDA Breakthrough Therapy designation for lead drug candidate lanifibranor in NASH @Duke_liverdoc @DrLoomba @NoureddinMD

New Viewpoint - Shiha et al - Redefining fatty liver disease: an international patient perspective

#NAFLD #MAFLD #fattyliver #livertwitter @EuropeLiver @Hep_Alliance @asscatinforma @ECPObesity